Today: October 23, 2018, 8:55 am
  
Business

Oxford Immunotec to Present at the Jefferies 2017 London Healthcare Conference

PR-Inside.com: 2017-11-10 15:02:01

OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced that Peter Wrighton-Smith, Chief Executive Officer, will present at the Jefferies 2017 London Healthcare Conference at 8:00 a.m. GMT on Wednesday, November 15, 2017.

About Oxford Immunotec

Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions.  The Company's first product is the T-SPOT®.TB test, which is used to test for tuberculosis infection.  The T-SPOT.TB test has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China.  The Company's second product line is a range of assays for tick-borne diseases, such as Lyme disease, obtained through the acquisitions of Imugen and Immunetics.  Also obtained through these acquisitions is the Company's third product line focused on screening for Babesia in donated blood, for which the Company is currently seeking FDA licensure.  The Company's fourth product line is focused on the transplantation market.  The Company is headquartered near Oxford, U.K. and in Marlborough, Mass.  Additional information can be found at www.oxfordimmunotec.com.

T-SPOT and the Oxford Immunotec logo are trademarks of Oxford Immunotec Ltd.  Immunetics is a trademark of Immunetics, Inc.

CONTACT:

For Media and Investor Inquiries:
Karen Koski
Head of Strategy and Investor Relations
Oxford Immunotec
Tel: +1 (508) 556-1377
kkoski@oxfordimmunotec.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Oxford Immunotec via Globenewswire




# 453 Words
Related Articles
 
More From Business
Buy LoL Smurfs Will Help You Find [..]
17 October 2018 – Buy LoL Smurfs is offering the one of a kind opportunity to buy league of legends [..]
Swiss Watches from the Best Online Shop [..]
22th October 2018 - Luxury Replica provides totally amazing products from Swiss. Swiss watches, the syntagm which breaks stereotypes [..]
Integra Certified Document Destruction Achieves Certification
ELKHART, INDIANA, UNITED STATES - October 11th, 2018 - Integra Certified Document Destruction(“Integra”) is proud to announce [..]
11th Asian Downstream Summit: Digital Transformation Awards [..]
SINGAPORE, Oct 10, 2018 - (ACN Newswire) - Voting for Asian Downstream Summit: Digital Transformation Awards 2018 has opened. The [..]
Indonesian Minister of SOEs officially closes 2018 [..]
Surabaya, East Java, Indonesia, Oct 9, 2018 - (ACN Newswire) - Minister of State-Owned Enterprises (SOEs) of Republic of Indonesia [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.